Literature DB >> 11437750

Quality of life in schizophrenia in India: comparison of three approaches.

A Lobana1, S K Mattoo, D Basu, N Gupta.   

Abstract

OBJECTIVE: To compare ratings of quality of life in patients with established schizophrenia in Chandigarh, India, in both subjective and objective view points and between patients' and relatives' ratings.
METHOD: Subjective and objective quality of life was assessed in 38 patients with schizophrenia using the Quality of Life Interview - Brief Version and WHO Quality of Life - Bref scale. Key family members were also interviewed using the same scales.
RESULTS: Subjective and objective quality of life are moderately well correlated (r = 0.43) and similar agreement was found between patients and relatives (r = 0.46).
CONCLUSION: Although quality of life is characteristically measured with subjects, the use of objective measures of quality of life and key informants of patients provide useful proxy measures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437750     DOI: 10.1034/j.1600-0447.2001.104001051.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  22 in total

1.  Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.

Authors:  Michael Ritsner; Rena Kurs; Anatoly Gibel; Yael Ratner; Jean Endicott
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

2.  Subjective quality of life of community living Sudanese psychiatric patients: comparison with family caregivers' impressions and control group.

Authors:  A W Awadalla; J U Ohaeri; A A Salih; A M Tawfiq
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

3.  Subjective quality of life of family caregivers of community living Sudanese psychiatric patients.

Authors:  Abdel W Awadalla; Jude U Ohaeri; Aziza A Salih; Adel M Tawfiq
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09-15       Impact factor: 4.328

4.  Carers' perspective in quality of life in epilepsy.

Authors:  Nitin Gupta; S K Mattoo
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

5.  Proxy and patients ratings on quality of life in patients with schizophrenia and bipolar disorder in Korea.

Authors:  Eun Joo Kim; Dong Ho Song; Se Joo Kim; Jin Young Park; Eun Lee; Jeong Ho Seok; Duk-In Jon; Hyun-Sang Cho
Journal:  Qual Life Res       Date:  2010-03-04       Impact factor: 4.147

6.  Cognitive insight and objective quality of life in people with schizophrenia and auditory hallucinations.

Authors:  Ruchika Rathee; Tanya M Luhrmann; Triptish Bhatia; Smita N Deshpande
Journal:  Psychiatry Res       Date:  2017-09-13       Impact factor: 3.222

7.  Subjective versus interviewer assessment of global quality of life among persons with schizophrenia living in the community: a Nordic multicentre study.

Authors:  Anita Bengtsson-Tops; Lars Hansson; Mikael Sandlund; Olafur Bjarnason; Jyrki Korkeila; Lars Merinder; Liselotte Nilsson; Knut Wollo Sørgaard; Hanne R Vinding; Thomas Middelboe
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

8.  Subjective quality of life of outpatients with diabetes: comparison with family caregivers' impressions and control group.

Authors:  Abdel W Awadalla; Jude U Ohaeri; Adel M Tawfiq; Shafika A Al-Awadi
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

9.  Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients.

Authors:  Yu-Tao Xiang; Yong-Zhen Weng; Chi-Ming Leung; Wai-Kwong Tang; Kelly Y C Lai; Gabor S Ungvari
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

10.  Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors.

Authors:  Yu-Tao Xiang; Yong-Zhen Weng; Chi-Ming Leung; Wai-Kwong Tang; Gabor S Ungvari
Journal:  Qual Life Res       Date:  2007-11-23       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.